
Glimipin MP 2mg/500mg/15mg Tablet ER
Marketer
Pinarc Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimipin MP 2mg/500mg/15mg Tablet ER
Metformin/glimepiride/pioglitazone extended-release tablets (2mg/500mg/15mg) are a triple-combination medication designed to manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It improves insulin efficiency, leading to reduced blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Take this medication with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; in that case, omit the missed dose and resume the regular schedule. Never double the dose. Overdosing can cause hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood sugar monitoring is crucial during treatment. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical advice before use. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption as it may heighten the risk of side effects.
Uses of Glimipin MP 2mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Glimipin MP 2mg/500mg/15mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. The Glimipin MP 2mg/500mg/15mg Extended-Release tablet should be administered with a meal.
Common Side effects of Glimipin MP 2mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimipin MP 2mg/500mg/15mg Tablet ER:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimipin MP 2mg/500mg/15mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medicine with a meal.
How Glimipin MP 2mg/500mg/15mg Tablet ER works:
Glimipin MP 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ diverse actions to enhance blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood sugar levels. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and improves insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimipin MP 2mg/500mg/15mg Tablet ER and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimipin MP 2mg/500mg/15mg tablet might pose pregnancy risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimipin MP tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimipin MP 2mg/500mg/15mg ER tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates use of this medication. Regular kidney function monitoring is recommended during treatment. Consult your physician for guidance.
LiverCAUTION
Patients with liver impairment should use Glimipin MP 2mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glimipin MP 2mg/500mg/15mg Extended-Release tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimipin MP 2mg/500mg/15mg Tablet ER :
Should you forget a dose of your Glimipin MP 2mg/500mg/15mg Extended-Release tablet, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimipin MP 2mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
